GlassScriptPhysician profile
Michael J Sullivan
NPI 1881097236
$36,574.55
in general payments reported to CMS, 2019-2025
8 companies · $36K in 2025
The $36K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $89.89 · 2022: $77.82 · 2023: $17.18 · 2024: $128 · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $35K · Travel and Lodging: $1,278 · Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $34,905.00 |
| Travel and Lodging | $1,277.86 |
| Food and Beverage | $223.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $36,322.58 | 2022-2025 | Sternalock Blu System, A&E Medical / Sternalock Xp Rigid Fixation System, Sternalock |
| Amgen INC. | $90.41 | 2024 | Evenity, Prolia |
| Pacira Therapeutics, INC. | $67.06 | 2021 | |
| Ferring Pharmaceuticals INC. | $22.83 | 2021 | |
| Depuy Synthes Sales INC. | $19.88 | 2024 | Monovisc |
| Urgo Medical North America, LLC | $18.12 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Stryker Corporation | $17.18 | 2023 | Ortholoc 2 Lapifuse |
| Heron Therapeutics, INC. | $16.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.